Form 4: Rocket Pharmaceuticals CEO Sells Shares
Insider Transaction (Form 4)
Gaurav Shah, CEO of Rocket Pharmaceuticals, Inc., sold 2,837 shares of common stock on August 13, 2026 for $3.38 per share.
Summary
- Open-market sale: disposed of 2,837 Common Stock at $3.38 ($9,592) on August 13, 2026; holds 1,058,887 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $9,592 of stock on the open market.
Insider Transactions
Gaurav Shah — Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-13 | Open-market sale | Common Stock | 2,837 | $3 | $9.6K | 1,058,887 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-13 | Open-market sale (2,837 shares) |
Keywords
insider transaction, Form 4, RCKT, ROCKET PHARMACEUTICALS, INC., bearish, Gaurav Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.